Oculis Pharmaceuticals vs Ray Therapeutics
Oculis Pharmaceuticals vs Ray Therapeutics, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Oculis Pharmaceuticals is on 4/100 and Ray Therapeutics on 53/100.
Where each one leads
Oculis Pharmaceuticals
- agent readiness: 39/100 against 21/100
- domain rating: 42/100 against 29/100
Ray Therapeutics
- our overall score: 53/100 against 4/100
At a glance
| Measure | Oculis Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| What it is | Global biopharmaceutical company developing breakthrough treatments for ophthalmic and neuro-ophthalmic conditions. | Pioneering vision restoration therapies for severe retinal degenerations. |
| Category | Biotechnology, Pharmaceuticals, Ophthalmology, Drug Development | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Not published | Services |
| Founded | 2017 | 2021 |
| Headquarters | Zug, Switzerland | Berkeley, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Oculis Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| Total funding | Not published | $243M |
| Latest round | Not published | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Oculis Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 4/100 | 53/100 |
| Traction | Not published | 40/100 |
| Team | Not published | 50/100 |
| Search visibility | 14/100 | 14/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 42/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Oculis Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4 |
Oculis Pharmaceuticals vs Ray Therapeutics: common questions
Which is better, Oculis Pharmaceuticals or Ray Therapeutics?
On our 0-100 score Ray Therapeutics rates higher (53/100 against 4/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Oculis Pharmaceuticals and Ray Therapeutics compare on the numbers?
Oculis Pharmaceuticals leads on agent readiness (39/100 against 21/100), domain rating (42/100 against 29/100). Ray Therapeutics leads on our overall score (53/100 against 4/100).
Read the full Oculis Pharmaceuticals review and pricing or the Ray Therapeutics review and pricing. You can also browse other Oculis Pharmaceuticals alternatives we track.